In this episode, we discuss the 2026 AI-driven revolution in biotechnology, highlighting IsoDDE as a breakthrough tool for atomic-level drug design and protein interaction. This engine surpasses previous models, such as AlphaFold 3, by identifying "cryptic pockets" and mastering induced-fit molecular binding. Complementary research introduces DNA methylation instability (DMI) as a vital metric for tracking biological entropy and software glitches that lead to aging and disease. Meanwhile, the biotech sector is experiencing a massive investment boom, with high-profile IPOs and startups leveraging generative AI to accelerate clinical trials. Technical discussions also showcase new bioinformatics plugins and AlphaGenome, a model designed to solve complex RNA splicing problems. Collectively, these developments represent a shift toward precision debugging of human biology to combat the fundamental causes of decay. Produced by Dr. Jake Chen.